Sales in our Government Pharma division this quarter grew 5.19% to $269.42 million compared to $256.13 million in the third quarter of 2008. This was mainly due to an increase in our participation in the bidding processes of the Instituto Mexicano del Seguro Social (IMSS), the Instituto de Seguridad Social del Estado de Mexico y Municipios (ISSEMYM) and the Centro Nacional de Equidad de Genero y Salud Reproductiva (National Center for Gender Equity and Reproductive Health).
As a percentage of total sales, this division went from representing 3.83% in 3Q08 to 3.84% during the third quarter of 2009.
HEALTH, BEAUTY, CONSUMER GOODS, GENERAL MERCHANDISE AND OTHER
Sales in our Health, Beauty, Consumer Goods, General Merchandise and Other division reached $595.08 million, a decline of 3.14% compared to the third quarter of 2008. This was due to a decrease in promotions and discounts in an effort to improve this division's operating margin.
This division represented 8.49% of GCS's total sales in 3Q09, slightly lower than the same period of the previous year when it accounted for 9.19% of the Group's total sales.
Publication sales decreased 6.39% during the quarter, primarily as a result of lower unit sales. This decrease in units was due to the fact that Citem stopped distributing publications to international clients as well as some publications that no longer met our minimal profitability requirements.
Consequently, this division's participation as a percentage of total sales went from 3.09% in 3Q08 to 2.76% in the third quarter of 2009.
There were marginal changes in the sales mix during the quarter. Private
Pharma sales represented 84.91% of total sales (compared to 83.88% during the
third quarter of 2008), while Government Pharma account
|SOURCE Grupo Casa Saba|
Copyright©2009 PR Newswire.
All rights reserved